Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John C Burnett

Showing results (1-10 of 336) with videos related to

Pageof 34
Sort By:
Heart Failure Clinics|March 28, 2007
Natriuretic peptides and remodeling in heart failureJohn C Burnett
Journal of Cardiology|December 2, 2006
Novel therapeutic directions for the natriuretic peptides in cardiovascular diseases: what's on the horizonJohn C Burnett
Nature|September 11, 2024
Long-lasting heart-failure treatment could be a game-changerJohn C Burnett
The New England Journal of Medicine|May 14, 2020
Vericiguat - Another Victory for Targeting Cyclic GMP in Heart FailureJohn C Burnett
JACC. Heart Failure|November 24, 2023
Innovative Dual Targeting of the Phosphodiesterase Family and Cyclic GMP Pathway in Heart FailureJohn C Burnett
Clinical Chemistry|August 1, 2019
Atrial Natriuretic Peptide, Heart Failure and the Heart as an Endocrine OrganJohn C Burnett
Circulation|December 7, 2005
Urocortin: advancing the neurohumoral hypothesis of heart failureJohn C Burnett
Circulation|July 8, 2010
A new signal from B-type natriuretic peptide in ST-elevation myocardial infarction: what does it mean for B-type natriuretic peptide and innovative diagnostics?Tomoko Ichiki, John C Burnett
Circulation|January 13, 2006
New cardioprotective agent K201 is natriuretic and glomerular filtration rate enhancingOndrej Lisy, John C Burnett
Circulation Research|April 6, 2002
Adrenomedullin: an autocrine/paracrine factor for cardiorenal protectionToshihiro Tsuruda, John C Burnett
Pageof 34

Showing results (1-10 of 336) with videos related to

Sort By:
Pageof 34
Heart Failure Clinics|March 28, 2007
Natriuretic peptides and remodeling in heart failureJohn C Burnett
Journal of Cardiology|December 2, 2006
Novel therapeutic directions for the natriuretic peptides in cardiovascular diseases: what's on the horizonJohn C Burnett
Nature|September 11, 2024
Long-lasting heart-failure treatment could be a game-changerJohn C Burnett
The New England Journal of Medicine|May 14, 2020
Vericiguat - Another Victory for Targeting Cyclic GMP in Heart FailureJohn C Burnett
JACC. Heart Failure|November 24, 2023
Innovative Dual Targeting of the Phosphodiesterase Family and Cyclic GMP Pathway in Heart FailureJohn C Burnett
Clinical Chemistry|August 1, 2019
Atrial Natriuretic Peptide, Heart Failure and the Heart as an Endocrine OrganJohn C Burnett
Circulation|December 7, 2005
Urocortin: advancing the neurohumoral hypothesis of heart failureJohn C Burnett
Circulation|July 8, 2010
A new signal from B-type natriuretic peptide in ST-elevation myocardial infarction: what does it mean for B-type natriuretic peptide and innovative diagnostics?Tomoko Ichiki, John C Burnett
Circulation|January 13, 2006
New cardioprotective agent K201 is natriuretic and glomerular filtration rate enhancingOndrej Lisy, John C Burnett
Circulation Research|April 6, 2002
Adrenomedullin: an autocrine/paracrine factor for cardiorenal protectionToshihiro Tsuruda, John C Burnett
Pageof 34